Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Maps Stats
Total: 29 #1
TickerYPF [NYSE]
CompanyYPF Sociedad Anonima
IndustryOil & Gas Integrated
Market Cap5.27BEPS (ttm)0.53
P/E12.48EPS this Y100.40%
Forward P/E3.10EPS next Y-29.65%
PEG-EPS past 5Y15.00%
P/S0.51EPS next 5Y-6.39%
P/B0.38EPS Q/Q-
Dividend-Sales Q/Q65.30%
Insider Own99.50%Inst Own47.70%
Insider Trans0.00%Inst Trans62.20%
Short Float5.01%Earnings-
Analyst Recom3.70Target Price4.35
Avg Volume2.35M52W Range2.82 - 6.64
Sep-08-22 09:00AMIs Most-Watched Stock YPF Sociedad Anonima (YPF) Worth Betting on Now? Zacks
Aug-31-22 08:50AMHere Is Why Bargain Hunters Would Love Fast-paced Mover YPF Sociedad Anonima (YPF) Zacks
Aug-30-22 09:15AMYPF Sociedad Anonima (YPF) Soars to 52-Week High, Time to Cash Out? Zacks
Aug-24-22 12:00PMHere's Why YPF Sociedad Anonima (YPF) is a Great Momentum Stock to Buy Zacks
Aug-22-22 06:03AMBeat the Market the Zacks Way: Dillard's (DDS), Sotherly Hotels (SOHO), Casey's (CASY) in Focus Zacks
Aug-15-22 09:49AMBest Value Stocks to Buy for August 15th Zacks
Aug-15-22 08:50AMWhy Fast-paced Mover YPF Sociedad Anonima (YPF) Is a Great Choice for Value Investors Zacks
Aug-15-22 08:20AMNew Strong Buy Stocks for August 15th Zacks
Jul-26-22 05:50PMYPF Sociedad Anonima (YPF) Gains As Market Dips: What You Should Know Zacks
Jul-22-22 06:00PMYPF Sociedad Anonima (YPF) Flat As Market Sinks: What You Should Know Zacks
CompanyCatalyst Pharmaceuticals, Inc.
Market Cap1.55BEPS (ttm)0.50
P/E29.68EPS this Y-48.10%
Forward P/E17.54EPS next Y20.80%
PEG-EPS past 5Y29.80%
P/S9.12EPS next 5Y-
P/B6.33EPS Q/Q75.00%
Dividend-Sales Q/Q45.90%
Insider Own7.30%Inst Own76.30%
Insider Trans-9.90%Inst Trans7.05%
Short Float7.15%EarningsAug 09/a
Analyst Recom2.00Target Price16.90
Avg Volume2.13M52W Range4.81 - 15.07
Sep-05-22 01:46PMCatalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Is Going Strong: Is the Market Following Fundamentals? Simply Wall St.
Aug-26-22 12:45PM3 Reasons Why Catalyst (CPRX) Is a Great Growth Stock Zacks
Aug-26-22 12:00PMHere's Why Catalyst Pharmaceutical (CPRX) is a Great Momentum Stock to Buy Zacks
Aug-26-22 09:40AMHas Aerie Pharmaceuticals (AERI) Outpaced Other Medical Stocks This Year? Zacks
Aug-26-22 08:30AMIf You Invested $1000 in Catalyst Pharmaceutical 10 Years Ago, This Is How Much You'd Have Now Zacks
Aug-24-22 08:03AMCatalyst Pharmaceuticals To Participate in Citi's 17th Annual BioPharma Conference GlobeNewswire
Aug-23-22 10:53AMGot $2,500? These 2 Small-Cap Monsters Are Crushing Tesla Stock Motley Fool
Aug-09-22 06:35PMCatalyst Pharmaceutical (CPRX) Q2 Earnings and Revenues Top Estimates Zacks
Aug-09-22 04:25PMCatalyst Pharmaceuticals Delivers Strong Second Quarter 2022 Financial Results with Record FIRDAPSE® Revenues and Provides Corporate Update GlobeNewswire
Jul-26-22 08:03AMCatalyst Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 9, 2022 GlobeNewswire
CompanyFirst Solar, Inc.
Market Cap14.53BEPS (ttm)1.76
P/E76.37EPS this Y17.40%
Forward P/E61.83EPS next Y2422.20%
PEG13.54EPS past 5Y25.30%
P/S5.86EPS next 5Y5.64%
P/B2.44EPS Q/Q-32.50%
Dividend-Sales Q/Q-1.30%
Insider Own0.30%Inst Own82.20%
Insider Trans-17.82%Inst Trans2.85%
Short Float4.91%EarningsJul 28/a
Analyst Recom2.70Target Price120.57
Avg Volume2.43M52W Range59.60 - 135.20
Sep-08-22Upgrade Goldman Sell → Buy $60 → $172
Sep-08-22 05:50AM3 Stocks to Buy If They Take a Dip Motley Fool
Sep-08-22 03:51AMGameStop, Asana, First Solar Rise Premarket; American Eagle Outfitters Falls Investing.com
Sep-07-22 06:42PMWhy First Solar Stock Climbed Today Motley Fool
Sep-04-22 05:16PMWhy First Solar Stock Rocketed More Than 28% in August Motley Fool
Sep-01-22 11:31AMWhy Is SunPower (SPWR) Up 7.9% Since Last Earnings Report? Zacks
Sep-01-22 09:56AMBiden praises U.S. investments by Micron, First Solar, Toyota, others: 'A direct result of my economic plan' MarketWatch
Sep-01-22 08:59AMThese 10 Renewable Energy Stocks Can Benefit as Europe Braces for Harsh Winter Insider Monkey
Aug-31-22 10:35AMFirst Solar Stock in 3 Minutes Motley Fool
Aug-31-22 09:44AMFirst Solar to Invest $1 Billion in New U.S. Factory Investopedia
Aug-31-22 08:52AMFirst Solar (FSLR) to Invest $1.2B to Boost Production Capacity Zacks
CompanyPROCEPT BioRobotics Corporation
IndustryMedical Devices
Market Cap2.00BEPS (ttm)-1.56
P/E-EPS this Y-9.30%
Forward P/E-EPS next Y22.00%
PEG-EPS past 5Y-
P/S40.27EPS next 5Y52.70%
P/B8.31EPS Q/Q33.20%
Dividend-Sales Q/Q6.40%
Insider Own3.30%Inst Own80.70%
Insider Trans-46.30%Inst Trans9.92%
Short Float5.80%EarningsAug 04/a
Analyst Recom2.00Target Price47.71
Avg Volume449.63K52W Range15.38 - 47.73
Aug-22-22 04:03PMPROCEPT BioRobotics Corp. to Present at 2022 Wells Fargo Healthcare Conference GlobeNewswire
Aug-05-22 05:30PMPROCEPT BioRobotics Corporation (PRCT) Q2 2022 Earnings Call Transcript Motley Fool
Aug-04-22 04:03PMPROCEPT BioRobotics Reports Second Quarter 2022 Financial Results and Increases 2022 Revenue Guidance GlobeNewswire
Jul-14-22 04:02PMPROCEPT BioRobotics to Report Second Quarter 2022 Financial Results on August 4, 2022 GlobeNewswire
Jul-10-22 08:32AMInsiders of PROCEPT BioRobotics Corporation (NASDAQ:PRCT) received good value on their investment after their US$11m purchase jumped US$3.3m in value Simply Wall St.
Jun-16-22 02:30PMProcept Biorobotics Corp Joins Elite Club Of Stocks With RS Ratings Over 90 Investor's Business Daily
Jun-09-22 09:01AMHow Much Of PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Do Insiders Own? Simply Wall St.
Jun-09-22 08:00AMPROCEPT BioRobotics Corporation Announces Additional Positive Coverage Policies Regarding Aquablation Therapy for Men with Enlarged Prostates GlobeNewswire
May-10-22 06:20AMNeed To Know: Analysts Are Much More Bullish On PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Revenues Simply Wall St.
May-05-22 04:02PMPROCEPT BioRobotics Reports First Quarter 2022 Financial Results and Increases 2022 Revenue Guidance GlobeNewswire
CompanyAlaunos Therapeutics, Inc.
Market Cap771.87MEPS (ttm)-0.25
P/E-EPS this Y3.70%
Forward P/E-EPS next Y-13.60%
PEG-EPS past 5Y22.60%
P/S1929.67EPS next 5Y-
P/B18.11EPS Q/Q56.30%
Dividend-Sales Q/Q-
Insider Own1.10%Inst Own40.90%
Insider Trans0.00%Inst Trans-23.07%
Short Float15.02%EarningsAug 15/b
Analyst Recom2.30Target Price3.80
Avg Volume3.16M52W Range0.41 - 3.50
Sep-07-22 08:30AMAlaunos Therapeutics to Participate in Upcoming Investor Conferences in September GlobeNewswire
Sep-06-22 08:00AMAlaunos Therapeutics Announces Early Clinical Data Showing Objective Clinical Response Using its TCR-T Cell Therapy GlobeNewswire
Aug-24-22 03:00PMAlaunos Therapeutics to Present at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference GlobeNewswire
Aug-15-22 07:00AMAlaunos Therapeutics Reports Second Quarter 2022 Financial Results GlobeNewswire
Aug-08-22 08:50AMAlaunos Therapeutics to Report Second Quarter 2022 Financial Results on August 15, 2022 GlobeNewswire
Aug-04-22 05:00PMAlaunos Therapeutics Appoints Abhishek Srivastava, Ph.D. as Vice President, Technical Operations GlobeNewswire
Jul-06-22 09:31AMThinking about buying stock in Verrica Pharmaceuticals, Scisparc, Adverum Biotechnologies, OneConnect Financial Tech, or Alaunos Therapeutics? PR Newswire
Jun-30-22 07:07AMIs Alaunos Therapeutics (NASDAQ:TCRT) Using Debt In A Risky Way? Simply Wall St.
Jun-27-22 08:00AMAlaunos Therapeutics and the National Cancer Institute Extend Cooperative Research and Development Agreement for Development of Personalized TCR-T Cell Therapies to 2025 GlobeNewswire
Jun-01-22 08:30AMAlaunos Therapeutics to Present at the Jefferies Healthcare Conference GlobeNewswire
CompanyADMA Biologics, Inc.
Market Cap524.44MEPS (ttm)-0.42
P/E-EPS this Y41.60%
Forward P/E-EPS next Y39.40%
PEG-EPS past 5Y20.40%
P/S4.76EPS next 5Y-
P/B4.81EPS Q/Q52.80%
Dividend-Sales Q/Q90.40%
Insider Own2.10%Inst Own74.70%
Insider Trans0.00%Inst Trans11.78%
Short Float16.09%EarningsAug 10/a
Analyst Recom1.70Target Price4.67
Avg Volume2.71M52W Range1.01 - 2.85
Aug-31-22 04:55PMTop Penny Stocks for September 2022 Investopedia
Aug-11-22 06:08PMWhy ADMA Biologics Stock Triumphed on Thursday Motley Fool
Aug-10-22 05:25PMAdma Biologics (ADMA) Reports Q2 Loss, Tops Revenue Estimates Zacks
Aug-10-22 04:05PMADMA Biologics Announces Second Quarter 2022 Financial Results and Provides Business Update GlobeNewswire
Aug-10-22 07:16AMADMA Biologics, Inc. (NASDAQ:ADMA) insiders placed bullish bets worth US$580k in the last 12 months Simply Wall St.
Aug-08-22 10:00AMAnalysts Estimate Vascular Biogenics (VBLT) to Report a Decline in Earnings: What to Look Out for Zacks
Aug-03-22 10:00AMAdma Biologics (ADMA) May Report Negative Earnings: Know the Trend Ahead of Q2 Release Zacks
Aug-03-22 07:00AMADMA Biologics to Report Second Quarter 2022 Financial Results on August 10, 2022 GlobeNewswire
Jun-26-22 09:11AMShareholders in ADMA Biologics (NASDAQ:ADMA) have lost 50%, as stock drops 12% this past week Simply Wall St.
Jun-21-22 07:00AMADMA Biologics Announces Addition to the Russell 2000® Index GlobeNewswire
TickerBJ [NYSE]
CompanyBJ's Wholesale Club Holdings, Inc.
IndustryDiscount Stores
Market Cap10.63BEPS (ttm)3.56
P/E21.81EPS this Y1.90%
Forward P/E19.80EPS next Y9.23%
PEG3.36EPS past 5Y54.30%
P/S0.58EPS next 5Y6.50%
P/B12.21EPS Q/Q28.60%
Dividend-Sales Q/Q22.20%
Insider Own0.80%Inst Own-
Insider Trans-14.52%Inst Trans-2.50%
Short Float3.46%EarningsAug 18/b
Analyst Recom2.30Target Price82.81
Avg Volume2.14M52W Range51.45 - 77.77
Sep-08-22 07:55AMThe Zacks Analyst Blog Highlights Marriott Vacations Worldwide, Marriott International, BJ's Wholesale Club Holdings, JAKKS Pacific and Enthusiast Gaming Holdings Zacks
Sep-08-22 06:30AMBJs Wholesale Club Reveals its List of Top 10 Toys for the Holiday Season Business Wire
Sep-07-22 12:45PMLooking for a Growth Stock? 3 Reasons Why BJ's (BJ) is a Solid Choice Zacks
Sep-07-22 09:40AMIs BJ's Wholesale Club (BJ) Stock Outpacing Its Consumer Discretionary Peers This Year? Zacks
Sep-07-22 08:16AM5 Big Winners From a Sharp Rise in Consumer Confidence Zacks
Sep-07-22 06:05AM2 Winning Stocks to Buy No Matter What the Market Is Doing Motley Fool
Sep-06-22 02:16PMYour Favorite Wholesale Club Is Steamrolling the Market Zacks
Sep-05-22 07:46AMColumbia Sportswear (COLM) Down More Than 10% in 3 Months Zacks
Sep-02-22 09:36AMPrestige Consumer (PBH) Brands & E-commerce Strength Bode Well Zacks
Sep-01-22 10:10AMCostcos August Sales Were Up Again. Membership Fees Could Rise Too. Barrons.com
TickerAES [NYSE, S&P 500]
CompanyThe AES Corporation
IndustryUtilities - Diversified
Market Cap17.95BEPS (ttm)-0.74
P/E-EPS this Y5.90%
Forward P/E15.40EPS next Y9.29%
PEG-EPS past 5Y4.38%
P/S1.53EPS next 5Y8.00%
P/B8.41EPS Q/Q-848.10%
Dividend2.33%Sales Q/Q14.00%
Insider Own0.30%Inst Own97.50%
Insider Trans-0.96%Inst Trans1.98%
Short Float1.37%EarningsAug 04/a
Analyst Recom1.80Target Price28.75
Avg Volume5.43M52W Range18.62 - 27.21
Sep-07-22 05:03PMHeat wave, record energy demand puts California in fossil-fuel conundrum MarketWatch
Sep-07-22 11:30AMWhy Is Dominion Energy (D) Down 1.1% Since Last Earnings Report? Zacks
Sep-07-22 03:44AMMong Duong Finance Holdings BV -- Moody's upgrades Mong Duong Finance's senior secured rating to Ba2; changes outlook to stable Moody's
Sep-07-22 03:37AMMong Duong Finance Holdings BV -- Moody's upgrades Mong Duong Finance's senior secured rating to Ba2; changes outlook to stable Moody's
Sep-01-22 09:55AMShould You Buy AES (AES) After Golden Cross? Zacks
Aug-29-22 06:20AMIs Invesco S&P 500 Equal Weight Utilities ETF (RYU) a Strong ETF Right Now? Zacks
Aug-25-22 01:18PMNorthern States Power Company (Wisconsin) -- Moody's announces completion of a periodic review for a group of North American Utilities issuers Moody's
Aug-16-22 07:14AMIs Now An Opportune Moment To Examine The AES Corporation (NYSE:AES)? Simply Wall St.
Aug-12-22 05:49PM6 Stocks to Play the Push for Renewable Energy Barrons.com
Aug-12-22 02:00AM6 Stocks to Play the Push for Renewable Energy Barrons.com
TickerENPH [NASD, S&P 500]
CompanyEnphase Energy, Inc.
Market Cap43.27BEPS (ttm)1.42
P/E223.07EPS this Y7.80%
Forward P/E63.48EPS next Y21.95%
PEG6.92EPS past 5Y22.50%
P/S24.93EPS next 5Y32.23%
P/B94.70EPS Q/Q92.60%
Dividend-Sales Q/Q67.70%
Insider Own1.20%Inst Own76.30%
Insider Trans-18.70%Inst Trans3.58%
Short Float3.57%EarningsJul 26/a
Analyst Recom2.00Target Price277.58
Avg Volume3.27M52W Range113.40 - 318.22
Sep-08-22 10:28AMTop-Ranked Solar Stock Shines Light On New Buy Point Investor's Business Daily
Sep-08-22 08:05AMDow Jones Futures: Market Rebounds, But Big Test Looms; 5 Hot Solar Plays Investor's Business Daily
Sep-07-22 04:32PMSolar ETF Invesco, IBD's Stock Of The Day, Heavily Weighted On Being Green Investor's Business Daily
Sep-07-22 09:05AMEnphase (ENPH) Extends Distribution Alliance With BayWa r.e. Zacks
Sep-07-22 08:30AMLet's Shine a Light on a Few Potential Solar Energy Trades TheStreet.com
Sep-07-22 08:03AMDow Jones Futures: Nasdaq Extends Losing Streak; Apple iPhone 14 On Call Investor's Business Daily
Sep-06-22 02:28PMEnphase Stock Is Rising. The Solar Firm Expanded a Partnership. Barrons.com
Sep-06-22 12:45PMEnphase Energy (ENPH) is an Incredible Growth Stock: 3 Reasons Why Zacks
Sep-06-22 08:08AMDow Jones Futures Rise; Energy Prices Lower Despite Surprise OPEC+ Move, Russia News Investor's Business Daily
Sep-06-22 08:00AMEnphase Energy and BayWa r.e. Expand Distribution Partnership in Europe GlobeNewswire
CompanySarepta Therapeutics, Inc.
Market Cap9.95BEPS (ttm)-5.87
P/E-EPS this Y27.50%
Forward P/E-EPS next Y23.50%
PEG-EPS past 5Y1.30%
P/S11.91EPS next 5Y-
P/B13.60EPS Q/Q-159.10%
Dividend-Sales Q/Q42.30%
Insider Own3.80%Inst Own83.60%
Insider Trans1.40%Inst Trans0.19%
Short Float8.18%EarningsAug 02/a
Analyst Recom1.90Target Price128.21
Avg Volume972.92K52W Range61.28 - 116.91
Sep-07-22 10:08AMClinical Hold on Sarepta's (SRPT) DMD Candidate Lifted by FDA Zacks
Sep-07-22 08:30AMSarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 2022-2023 Academic Year GlobeNewswire
Sep-06-22 09:27AMFDA Lifts Clinical Hold On Sarepta's Dose-Expansion Part Of Duchenne Trial Benzinga
Sep-06-22 08:45AMSarepta Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference GlobeNewswire
Sep-06-22 08:30AMSarepta Therapeutics Announces That FDA has Lifted its Clinical Hold on SRP-5051 for the Treatment of Duchenne Muscular Dystrophy GlobeNewswire
Sep-02-22 11:31AMMirati (MRTX) Up 5.3% Since Last Earnings Report: Can It Continue? Zacks
Sep-01-22 11:31AMWhy Is Sarepta Therapeutics (SRPT) Up 13.8% Since Last Earnings Report? Zacks
Aug-31-22 05:59PMSarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Aug-30-22 01:47PM15 Biotech Stocks That Hit Year Highs Over The Last Week, Including Sarepta, Axsome Investor's Business Daily
Aug-29-22 10:23AM3 Biotech Stocks You Can Buy and Hold for the Next Decade Motley Fool